Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Head & Neck 2Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Anemia 1

Interventions

Cisplatin 53Radiotherapy 36Fluorouracil 16Paclitaxel 15Radiotherapy, Intensity-Modulated 14Docetaxel 12Cetuximab 12Carboplatin 12Platinum 6Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 5Radiation 4Polymerase Chain Reaction 4Nimorazole 4Drug Therapy 4Chemotherapy, Adjuvant 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Taxes 3Magnetic Resonance Spectroscopy 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Afatinib 3vandetanib 2pembrolizumab 2dehydroftorafur 2Surgical Procedures, Operative 2Specimen Handling 2Reverse Transcriptase Polymerase Chain Reaction 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Epoetin Alfa × Head & Neck × Clear all
NCT00004917 2020-10-22

Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anemia, Head and Neck Neoplasms

NCT00017277 2012-09-24

Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡